Description
JAK2 inhibitor V (Z3) is an inhibitor of JAK2 that exhibits anticancer activity. In erythroleukemia cells, this compound induces cell cycle arrest and suppresses cellular proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
JAK2 inhibitor V (Z3) is an inhibitor of JAK2 that exhibits anticancer activity. In erythroleukemia cells, this compound induces cell cycle arrest and suppresses cellular proliferation.
| Cas No. | 195371-52-9 |
|---|---|
| Purity | ≥98% |
| Formula | C23H24N2O |
| Formula Wt. | 344.46 |
| IUPAC Name | 2-Methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-1-butanone |
| Synonym | JAK2 inhibitor V, Z3 |
| Solubility | Soluble in DMSO or Ethanol |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Sayyah J, Magis A, Ostrov DA, et al. Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. Mol Cancer Ther. 2008 Aug;7(8):2308-18. PMID: 18723478.
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
Imidazole; 14-α demethylase inhibitor.
Derivative of aristolochic acid found in Asarum...
c-Raf inhibitor.
Found in Piper longum; TxA2 antagonist, ubiquit...
Laminin-derived peptapeptide.
p38 MAPK inhibitor.
Mixture of oligomycins A, B, C; oxidative phosp...
Anthracycline, DNA intercalator; topoisomerase ...
Triterpene saponin found in Panax.
Negative control for PKC activation.
Selective HDAC4 and HDAC5 inhibitor.
Endogenous peptide hormone, involved in enteric...
Natural anthraquinone derivative
Synthetic steroid hormone; AR and ER antagonist...
PKC and S6 kinase substrate.
Nucleoside (cytidine) analog; RT and telomerase...
Benzisoxazole; 5-HT7 and NMDA agonist, D-amino ...
Bactericidal
Geldanamycin derivative; HSP90 inhibitor.